The group was established in 2020 and comprises two manufacturing entities: Shandong Doer Pharmaceutical Co., Ltd. and Shandong Doer New Materials Technology Co., Ltd., as well as a research and development entity, Shandong Doer Pharmaceutical R&D Co., Ltd. Located in the Runxin Industrial Park, Dingtao District, Heze City, Shandong Province, the group is a comprehensive chemical enterprise driven by technological innovation, integrating scientific research, design, production, and technical services.

The group operates facilities with an annual production capacity of 2,000 tons of di-tert-butyl dicarbonate, 60 tons of 3,4-dihydroxybenzaldehyde, 60 tons of 4'-chloro-2-aminobiphenyl, 200,000 tons of medical-grade GPPS, and an intelligent CDMO product R&D and production workshop. The group focuses on developing customer demand-oriented customized processing services for pharmaceutical and pesticide products, the high-end PS industry chain, and the specialty engineering plastic polyimide industry chain, among other projects.

Shandong Doer Pharmaceutical Co., Ltd. actively promotes technological innovation by collaborating with prestigious institutions such as Tsinghua University and China Pharmaceutical University, jointly establishing Shandong Doer Pharmaceutical R&D Co., Ltd. and attracting high-end talent. The company's technical team possesses strong R&D capabilities and scientific resources in chemical technology, utilizing well-equipped pilot and semi-industrial scale bases for technology transfer, with extensive experience in industry-academia-research collaboration. The company is committed to developing world-leading technologies in energy chemicals, fine chemicals, pharmaceutical chemicals, and chemical environmental protection, aiming to build a green, safe, and diversified intelligent pharmaceutical manufacturing industrial cluster.